Skip to Content

DocMorris AG DOCM

Morningstar Rating
CHF 85.55 +3.00 (3.63%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DOCM is trading within a range we consider fairly valued.
Price
CHF 83.44
Fair Value
CHF 121.69
Uncertainty
Very High
1-Star Price
CHF 765.77
5-Star Price
CHF 36.88
Economic Moat
Nrcc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DOCM is a good fit for your portfolio.

Trading Information

Previous Close Price
CHF 82.55
Day Range
CHF 82.8585.70
52-Week Range
CHF 28.52101.60
Bid/Ask
CHF 0.00 / CHF 0.00
Market Cap
CHF 1.01 Bil
Volume/Avg
64,718 / 126,196

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.04
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Germany, and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Small Value
Total Number of Employees
1,453

Comparables

Valuation

Metric
DOCM
GALE
NBLY
Price/Earnings (Normalized)
21.5437.89
Price/Book Value
2.362.401.42
Price/Sales
1.040.940.95
Price/Cash Flow
13.9613.98
Price/Earnings
DOCM
GALE
NBLY

Financial Strength

Metric
DOCM
GALE
NBLY
Quick Ratio
1.270.880.40
Current Ratio
1.631.341.14
Interest Coverage
−5.3621.40−0.27
Quick Ratio
DOCM
GALE
NBLY

Profitability

Metric
DOCM
GALE
NBLY
Return on Assets (Normalized)
−12.29%10.03%−1.59%
Return on Equity (Normalized)
−28.68%20.87%−2.93%
Return on Invested Capital (Normalized)
−12.54%18.15%0.86%
Return on Assets
DOCM
GALE
NBLY
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
WBA
Walgreens Boots Alliance IncHzdhmdnmBhyk$15.2 Bil
RADLY
Raia Drogasil SA ADRYvkzqd$8.3 Bil
ALBBY
Alibaba Health Information Technology Ltd ADRVcngb$6.1 Bil
ALBHF
Alibaba Health Information Technology LtdJqrffm$6.1 Bil
CLCGY
Clicks Group Ltd ADRKcyhl$3.6 Bil
TSUSF
Tsuruha Holdings IncRpbdysm$3.1 Bil
SGIPF
Sugi Holdings Co LtdPtrst$2.8 Bil
SAEYY
Redcare Pharmacy NV ADRYrz$2.7 Bil
SHPPF
Redcare Pharmacy NVXwqbn$2.5 Bil
ZRSEF
DocMorris AGSwb$1.1 Bil

Sponsor Center